Cyclacel Pharmaceuticals Inc. shares (NASDAQ:CYCC) fell 22.5 percent to $1.10 on Wednesday after the Berkeley Heights, N.J.-based company priced a follow-on offering of 10 million shares of common stock at $1 each, a 29 percent discount to the closing price of $1.42 per share on Tuesday.